Study on the Optimal Strategy for Acute-on-chronic Liver Failure With Integrative Treatment
Study on the Optimal Strategy for Acute-on-chronic Liver Failure Combined With Traditional Chinese and Modern Medicine: a Multi-center, Randomized and Controlled Study
Sponsor: Beijing 302 Hospital
This NA trial investigates Acute on Chronic Liver Failure and Hepatitis B and is currently completed. Beijing 302 Hospital leads this study, which shows 10 recorded versions since 2019 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2022 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Oct 2021 — Apr 2022 [monthly]
Recruiting NA
-
Feb 2021 — Oct 2021 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Recruiting NA
-
Sep 2019 — Jan 2021 [monthly]
Recruiting NA
-
May 2019 — Sep 2019 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2019 — May 2019 [monthly]
Not Yet Recruiting NA
-
Aug 2018 — Feb 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Beijing 302 Hospital
- Beijing Ditan Hospital
- Beijing YouAn Hospital
- Fuzhou Infectious Hospital
- Guangxi University of Chinese Medicine
- Hangzhou Xixi hospital
- Hepatology hospital of Jilin Province
- Huazhong University of Science and Technology
- Hubei Hospital of Traditional Chinese Medicine
- Public Health Clinical Center of Chengdu
- Shanghai Public Health Clinical Center
- Shenzhen Third People's Hospital
- Shenzhen traditional Chinese medical hospital
- ShuGuang Hospital
- Sun Yat-sen University
- The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
- The Sixth People's Hospital of Shenyang
- Tianjin Second People's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Beijing, China , Changchun, China , Changsha, China , Chengdu, China , Fuzhou, China , Hangzhou, China , Shanghai, China , Shenyang, China , Tianjin, China , Wuhan, China and 1 more location